Clinical trial
Safety and Efficacy of APD356 in the Treatment of Obesity
NCT00116740 · Eisai Inc., Industry · Completed
Key facts
| NCT number | NCT00116740 |
|---|---|
| Title | Safety and Efficacy of APD356 in the Treatment of Obesity |
| Official title | A 12-Week, Dose-Ranging, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of APD356 in Obese Patients |
| Lead sponsor | Eisai Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | APD356 |
| Enrollment | 400 |
| Start date | Jun 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Jul 1, 2005 |
| Last update posted | Sep 12, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: